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Abstract 
Cross and co-resistance to antimicrobials are presented for 765 Danish Escherichia coli isolates of 
porcine origin from 2009-2013. All isolates and data originate from the DANMAP surveillance but 
have not previously been used to describe the occurrence of cross and co- resistance. Data 
presented here clearly indicate the ability of low classified antimicrobials as ampicillin to uphold 
resistance to critical important antimicrobials for human treatment. 
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It is generally believed that prevalence of antimicrobial resistance is a result of usage of 
antimicrobial (Levy 1997). This usage will select for already existing resistance bacteria enhancing 
their prevalence. General observations of prevalence of resistance have in contradiction to this 
shown non linear relationship. Major changes of usage can occur while the prevalence of 
antimicrobial resistance prevails (Aarestrup 1999). Co - and cross resistance mechanisms are 
most likely responsible for this observation (Pitout and Laupland 2008).  In general, surveillance 
data is not presented in ways that visualize this (Anonymous 2014) and the European Food safety 
Authority experts have lately suggested that analysis of surveillance data should include clear 
structured tables that visualize co - and cross resistance (EFSA 2012).   
Here we analyze data for 765 porcine E. coli isolates obtained from 2009-2013 as part of the 
Danish Integrated Antimicrobial Resistance Monitoring and Research Programme (DANMAP) 
(Table 1) to investigate for presence of cross- and co-resistance. Isolates were collected from fecal 
samples collected at slaughterhouses in Denmark each year. Single isolates representing farms in 
Denmark were isolated by first directly plaiting on Drigalski agar, then picking yellow colonies, 
incubating these in BBL CHROM agar Orientation Medium and isolated as red colonies from this 
media after o.n. incubation at 37 °C. For more details see Anonymous 2014. 
Isolates were tested for antimicrobial resistance to 16 compounds, representing eight distinct 
antimicrobial structural families. The compounds include tetracyclines, β-lactams, sulphonamides, 
trimethoprim, aminoglycosides, amphenicols, quinolones and polymyxins (colistin) (Anonymous 
2014) representing antimicrobial classes, which WHO has classified according to their importance 
for treatment of human infections (Collignon et al. 2009). Resistance was defined according to 
EUCAST epidemiological cut-off values and antimicrobial resistance testing was done as 
microbroth dilution MIC with Sensititre and inoculation procedures according to CLSI guidelines 
and European standard (ISO 20776-1:2006)(Anonymous 2014) 
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Co-resistance was defined as resistance to different antimicrobial compounds belonging to the 
same chemical structure group (β-lactams, aminoglycosides, amphenicols and quinolones). Co-
resistance can be encoded by one resistance determinant. Cross-resistance is defined as 
resistance to two or more compounds belonging to different distinct antimicrobial resistance 
compound and will be encoded by series of antimicrobial resistance determinants.  
Overall 45% (n=334) of the tested isolates were fully susceptible to all antimicrobials tested and 
32% (n=245) were found multi-resistant using the EFSA definition of resistance to more than five 
antimicrobial families (EFSA 2012),. Resistance profiles were sustained in all tested years. The 
most dominant multi-resistant profile was resistance to ampicillin (AMP), streptomycin (STR), 
sulphonamides (SUL), tetracycline (TET) and trimethoprim (TRI); 6% (n=48) of the isolates had 
this profile. 27% of all isolates (n=205) were resistant to β-lactams. All cephalosporin-resistant 
(tested with the 3rd generation cephalosporins cefotaxime and ceftiofur) isolates (n=5) had cross-
resistance to ampicillin due to genetic background. Two percent of the ampicillin (n=205) resistant 
isolates were cross-resistance to cephalosporins.  
Forty-two percent of all isolates (n=320) where resistance to streptomycin. Among aminoglycoside-
resistant isolates, resistance is encoded by numerous resistance genes (Shaw et al. 1993), all 
giving different patterns for cross-resistance (Hedges and Shannon 1984). 92% of the 
spectinomycin-resistant isolates (n=159), 85% of the neomycin-resistant isolates (n=34), 46% of 
the spectinomycin (n=147) and 9% of the neomycin (n=9) resistant isolates showed cross-
resistance to streptomycin. All apramycin-resistant isolates (n=3) and gentamicin-resistant isolates 
(n=5) were cross-resistant to streptomycin due to genetic background for resistance. This has been 
reported previously (Hedges and Shannon 1984, Sandvang and Aarestrup 2000).   
Less than one percent of all tested isolates were resistant to amphenicols but due to common 
genetic background for resistance all florfenicol-resistant E. coli isolates (n=4) had cross-resistance 
to chloramphenicol. However, only 12 % of the chloramphenicol-resistant E. coli isolates (n=34) 
showed cross-resistance to florfenicol.  
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Less than one percent of the tested isolates (n=5) were quinolone-resistant but due to a shared 
genetic background for antimicrobial resistance, cross-resistance was observed between 
resistance to nalidixic acid and ciprofloxacin (n=5).  
The highest levels of co-resistance were found among isolates resistant to sulphonamides (five 
distinct structural groups). Among those isolates 100 % of the quinolone-resistant isolates (n=5), 
91-100% of the amphenicols (chloramphenicol (91%, n=34) and florfenicol (100%, n=4)) resistant 
isolates,  91-100% of amphenicols (91% chloramphenicol (n=34) and 100% florfenicol (n=4)) 
resistant isolates, 93% of trimethoprim (n=170) resistant isolates, 80-91% of the aminoglycoside 
(gentamicin (80%, n=5) and  neomycin (91%, n=34)) resistant isolates and 80-85% of the  β-
lactams (ampicillin (85%, n=205) and 3rd generation cephalosporin (80%, n=5)) resistant isolates 
were co-resistant to sulphonamides.  
High co-resistance was furthermore found among isolates resistant to streptomycin (four families), 
tetracycline (two families), ampicillin (two families) and trimethoprim (one family).  
Surprisingly, results presented here shows that while 93% of the sulphonamides-resistant isolates 
were co-resistant to trimethoprim only 63 % of trimethoprim resistant isolates were co-resistant to 
sulphonamides. These two antimicrobials are often used in combination (Anonymous 2014), and 
therefore, an equal prevalence of co-resistance was expected and even though encoded by 
difference resistance genes are often found together on plasmids (Freitag et al.  2017). No 
explanation for this can be given. 
Co- and cross-resistance could cause the observed disproportions between the prevalence of 
resistance and the quantitative usage of some of the antibiotics (Anonymous 2014). Co- and cross-
resistance to commonly used antimicrobials, such as tetracycline, ampicillin, sulphonamides and 
streptomycin, may thus uphold resistance to other chemically distinct antimicrobial families. In 
accordance to this, usage of antimicrobials not listed as critically important for human treatment 
can uphold already developed resistance to critically important antimicrobials, as well as selecting 
multi-resistant profiles otherwise limiting treatment possibilities. Co-resistance can thus be the 
driver for presence of resistance to the critical important antimicrobials for human treatment in E. 
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coli in Danish pigs several years after the industry has stopped using these antimicrobials, making 
it extremely difficult to eliminate prevalence of unwanted antimicrobial resistance. Surprisingly, all 
isolates resistant to 3rd generation cephalosporins, fluoroquinolones and gentamicin were resistant 
to ampicillin. Cross-resistance between ampicillin and 3rd generation cephalosporins is not 
surprising, but co-resistance to quinolones and the aminoglycosides apramycin/gentamicin was not 
expected. This result could indicate that the usage of ampicillin can uphold already acquired 
resistance to these critical important antimicrobials. The same level of co-and cross resistance 
between tetracycline and other critical antibiotics was not observed indicating that usage of 
ampicillin potentially could be more important for upholding critical resistance in pig production in 
Denmark than tetracycline (Anonymous 2014). Most of the isolates containing resistance to 
important antimicrobials are multi-resistant leaving few options to eliminate infections. It was also 
observed that isolates with specific multi-resistant profiles persisted over the study period and 
made up a fair proportion (32%) of the 765 randomly picked E.coli isolates from pigs. Distinct 
resistance profiles, such as AMP-STR-SUL-TET-TRI (6%, n=9) prevailed during the whole period. 
A closer review of all resistance profiles reveals a backbone profile (AMP-STR-SUL) found in 20% 
of the isolates (151 of 765 isolates). This combination is found in almost all multi-resistant isolates 
showing the addition of new antimicrobial families to this backbone.  
The data presented shows the presence of cross- and co-resistance among Danish porcine E. coli. 
Such data have not previously been retrieved from the DANMAP. Data presented here clearly 
indicate the ability of low-classified antimicrobials as ampicillin to uphold resistance to critical 
important antimicrobials.  
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Table 1. Co- and cross-resistance in E. coli isolates from 2009-2013 in pigs. 
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ANTIB TET AMP CTX CEF SUL TRI STR SPE NEO APR GEN CHL FLO NAL CIP COL 
263 34  TET 100 50 1 1 63 44 71 29 10 1 2 8 1 2 2 
 
205 27  AMP 64 100 2 2 85 64 83 21 11 1 2 9 1 2 2 
 
5 1  CTX 40 100 100 100 80 60 60 40 
   
20 
    
5 1  CEF 40 100 100 100 80 60 60 40 
   
20 
    
252 33  SUL 66 69 2 2 100 63 85 33 12 1 2 12 2 2 2 
 
170 22  TRI 69 78 2 2 93 100 82 28 11 1 2 11 1 2 2 
 
320 42  STR 58 53 1 1 67 43 100 46 9 1 2 7 1 1 1 
 
159 21  SPE 47 28 1 1 53 30 92 100 8 1 1 11 1 
   
34 4  NEO 76 68 
  
91 53 85 38 100 
  
3 
    
3 0.4  APR 100 100 
  
67 67 100 33 
 
100 100 33 
 
33 33 
 
5 1  GEN 80 100 
  
80 80 100 20 
 
60 100 60 40 20 20 
 
34 4  CHL 59 56 3 3 91 56 68 53 3 3 9 100 12 3 3 
 
4 1  FLO 50 75 
  
100 50 100 25 
  
50 100 100 
   
5 1  NAL 100 100 
  
100 80 80 
  
20 20 20 
 
100 100 
 
5 1  CIP 100 100 
  
100 80 80 
  
20 20 20 
 
100 100 
 
2 0.3  COL 
 
50 
             
100 
 
* N: total number of resistant isolates 
Table 1 
Table of co- and cross resistance among 765 E. coli of porcine origin isolated in Denmark 2009-2013. 
Numbers given are in percentage of the total bacteria resistant to antimicrobials given as columns for the 
individual tested 16 antimicrobials belonging to eight structural families.  Total number of resistant are given 
in column one (n). Percentage of the total amount of tested bacteria are given in column  n/N, where N is the 
total number of tested isolates and n is the number of resistant isolate to the tested antimicrobial. Percentage 
below 1% is excluded from the Table. Abbreviations: TET (tetracycline), AMP (ampicillin), CTX (cefotaxime), 
CEF (ceftiofur), SUL (sulfonamide), TRI (trimethoprim), STR (streptomycin), SPE (spectinomycin), NEO 
(neomycin), APR (apramycin), GEN (gentamicin), CHL (chloramphenicol), FLO (florfenicol), NAL (nalidixic 
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acid), CIP (ciprofloxacin), COL (colistin).  Hatched grey areas indicate higher percentage of co- and cross 
resistance. 
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Highlights 
 Presenting prevalence of co- and cross-resistance 
 Identifying possible co-selection of antimicrobial resistance among tested isolates 
 The importance of usage of ampicillin for production animals 
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